Life depends on double-stranded DNA unwinding and separating into single strands that can be copied for cell division. St. Jude Children’s Research Hospital scientists have determined at atomic resolution the structure of machinery that drives the process. The research appears today in the journal Nature Communications.
The process may also help to solve what the study’s senior researcher called one of the greatest mysteries of biology: How double-stranded DNA separates into single strands to start the replication process. “Based on the crystal structure in this research, we propose that a rotary mechanism drives the transformation to initiate DNA replication,” said Eric Enemark, Ph.D., an associate member of the St. Jude Department of Structural Biology.
Before cells divide, their DNA must be precisely copied in a process called replication. This research focused on a ring-shaped enzyme called the minichromosome maintenance or MCM complex that plays a central role. During DNA replication, the MCM complex is positioned at the fork where double-stranded DNA separates into single strands. Those strands are copied to produce a new DNA molecule.
Enemark and his colleagues have produced the first atomic resolution image of the MCM complex bound to single-strand DNA and the molecules that fuel replication.
The image captured key structural details, including the orientation of both the MCM complex and single-strand DNA. The elements illustrated how the process works like a pulley system to “pull” a single strand of DNA through the MCM complex and unwind the DNA.
The same mechanism may also explain how DNA replication begins, Enemark said. Prior to cell division, double-stranded DNA is encircled by two separate MCM complex enzymes. Based on the newly determined structure of the replication machinery, the researchers proposed that the MCM complexes begin to move in different directions, leading to separation of double-stranded DNA into single strands.
“This single event is at the heart of cell division and presents the essence of life in its most streamlined form,” he said.
The co-first authors are Martin Meagher, Ph.D., of the Enemark laboratory and Leslie Epling, formerly of St. Jude and now of Incyte Research Institute, Wilmington, Delaware.
The research was supported in part by a grant (GM098771) from the National Institute of General Medical Sciences; a grant (CA021765) from the National Cancer Institute, both part of the National Institutes of Health; and ALSAC, the fundraising and awareness arm of St. Jude.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food — because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.